NL-OMON54368招募中3 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product - LTF-304
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 64（—）
入选标准
- •1.Provision of written informed consent for this study by the subject or
- •subject*s parent(s)/legal guardian(s) and written informed assent by subject,
- •if applicable
- •2.Have received eli-cel in a parent clinical study
- •3.Able to comply with study requirements
排除标准
- •There are no exclusion criteria for this Study.
研究者
相似试验
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductEUCTR2015-002805-13-DEbluebird bio, Inc67
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductEUCTR2015-002805-13-NLbluebird bio, Inc60
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductCerebral Adrenoleukodystrophy (CALD)MedDRA version: 20.0Level: PTClassification code 10051260Term: AdrenoleukodystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2015-002805-13-FRbluebird bio, Inc.25
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductEUCTR2015-002805-13-GBbluebird bio, Inc60
进行中（未招募）
1 期
ongterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug ProductCerebral Adrenoleukodystrophy (CALD)MedDRA version: 20.0Level: PTClassification code: 10051260Term: Adrenoleukodystrophy Class: 100000004850MedDRA version: 20.0Level: SOCClassification code: 10010331Term: Congenital familial and genetic disorders Class: 21CTIS2024-513904-33-00Bluebird Bio Inc.64